Favorable Risk Renal Cancer Of Course Monotherapy is the Obvious Right Answer

Favorable Risk Renal Cancer Of Course Monotherapy is the Obvious Right Answer

kidneycancer

7 months
42 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Walter Stadler, MD FACP Dean for Clinical Research Deputy Director Comprehensive Cancer Center University of Chicago discusses Favorable Risk Renal Cancer Of Course Monotherapy is the Obvious Right Answer at the 18th International Kidney Cancer Symposium 2019, Miami, FL.
Up Next Autoplay